| Gene symbol | MAGEA4 | Synonyms | CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | MAGE family member A4 | ||||
| GTO ID | GTC1476 |
| Trial ID | NCT02096614 |
| Disease | Solid Tumor |
| Altered gene | MAGE-A4 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | TBI-1201 |
| HLA | HLA-A*24:02 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Multi-center, Investigator Initiated Phase 1 Study of MAGE-A4 Specific TCR Gene Transferred T Lymphocytes With Solid Tumors |
| Year | 2014 |
| Country | Japan |
| Company sponsor | Mie University |
| Other ID(s) | 1201-01 |
| Cohort1: dose level 1_cyclophosphamide | |||||||||
|
|||||||||
| Cohort2: dose level 2_cyclophosphamide | |||||||||
|
|||||||||
| Cohort3: dose level 2_cyclophosphamide_fludarabine | |||||||||
|
|||||||||